Purchase Order 75N94026P00081
- Not listed
- The National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, awarded a $11,845 firm-fixed-price purchase order to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for a service agreement to provide the NICHD SR-X Biomarker Detection System equipment, which supports NICHD's biomedical research programs. Quanterix is the prime...
- Quanterix Corporation has been awarded an $11,845 purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide a one-year service agreement for biomarker detection and microplate washer equipment. The contract calls for Quanterix to deliver biomarker detection and microplate washing services in support of NICHD's research programs. Performance will take place in Bethesda, Maryland over the one-year period beginning January 14, 2024 and...
- The National Institute of Child Health and Human Development (NICHD), a component of the Department of Health and Human Services' National Institutes of Health (NIH), has awarded a $11,041 purchase order to Quanterix Corporation of Billerica, Massachusetts. Under this firm fixed price contract running from August 2023 through August 2024, Quanterix will provide NICHD with supplies necessary for neurology testing, specifically a 2-plex biomarker assay kit to detect glial fibrillary acidic protein...
- This is a $84,013.00 firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Quanterix Corporation. The contract is for the development of custom assays, including reagents, for use on Quanterix's Simoa (single molecule array) instruments. This work supports NICHD's biomedical research programs. The contract was awarded without a set-aside designation,...
- This federal contract award, valued at $14,525.80, was issued by the National Institute of Child Health and Human Development (NICHD) to Quanterix Corporation, a life sciences company that specializes in ultra-sensitive digital biomarker detection technology. The contract, titled "NICHD - INFLIGHT V2 ADVANTAGE KIT", is a firm-fixed-price purchase order with a completion date of September 30, 2024. Quanterix has also been awarded an indefinite delivery contract (IDV) by the Department...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Quanterix Corporation for the supply of Neurology 4-Plex A Advantage Kits, SR-X Disc Kits, and Wash Buffers, with a total value of $30,152.63. The award has a completion date of July 31, 2024. Quanterix is a life sciences company that specializes in ultra-sensitive digital biomarker detection technology, and has provided various products and services...
- This is a firm-fixed-price purchase order awarded by the National Institute of Nursing Research (NINR), a civilian agency, to Quanterix Corporation, a for-profit manufacturer of advanced biomedical equipment and research services. The $24,416.10 contract is for the supply of Quanterix's Simoa HD-X Analyzer, SR-X Biomarker Detection System, and related maintenance services. Quanterix is the prime contractor, and there are no set-aside designations mentioned. The contract award is not associated...
- The National Institute of Child Health and Human Development (NICHD) awarded a $20,552.40 firm fixed-price purchase order to Agilent Technologies Inc.'s Customer Service and Sales division for maintenance services on laboratory equipment at its Bethesda, Maryland facility. The contract, awarded on August 8, 2025, has an ultimate completion date of August 7, 2026, and represents a severable services contract with no set-aside designation. Agilent Technologies Inc., a global leader in life...
- This contract award is for maintenance and support services for a QUANTERIX HD-X machine, which is a highly sensitive and specialized piece of equipment used for detecting and quantifying proteins at extremely low levels. The $135,070.70 firm-fixed-price purchase order was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to the Quanterix Corporation. The award was made without a set-aside and is for a one-year base...
- The U.S. National Institute on Aging (NIA) awarded a firm-fixed-price purchase order contract to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The $172,938.00 contract is for maintenance service on a Simoa HD-X Analyzer used in the agency's biomedical research. The contract has a period of performance through January 11, 2029 and does not have a set-aside designation. Quanterix provides advanced instruments, assay kits, and...
The National Institute of Child Health and Human Development (NICHD) awarded a $25,496 firm fixed-price purchase order to Quanterix Corporation for laboratory equipment maintenance services on an SR-X Biomarker Detection System. The contract, issued on January 14, 2026, is severable in nature and extends through January 13, 2028. Work will be performed at Quanterix's facility in Billerica, Massachusetts. This award carries no small business or other set-aside designation, reflecting the specialized and unique technological capabilities required for maintenance of Quanterix's advanced biomarker detection equipment. Quanterix Corporation is a life sciences company specializing in ultra-sensitive digital biomarker detection technology, primarily through its proprietary Simoa (single molecule array) platform. The company has an established relationship with NICHD and other National Institutes of Health components, providing sophisticated research equipment and support services to advance biomedical research initiatives. This maintenance contract supports NICHD's ongoing research operations by ensuring continued functionality of the SR-X system, enabling the detection of biomarkers at extremely low concentrations from small sample volumes—a critical capability for advancing child health research and diagnostics.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 12/23/25 |